Department of Behavioural Medicine, University of Oslo, Oslo, Norway
Department of Endocrinology, Obesity and Nutrition, Vestfold Hospital Trust, Tønsberg, Norway.
BMJ Open. 2023 Aug 28;13(8):e071332. doi: 10.1136/bmjopen-2022-071332.
Obesity is linked to increased loneliness and less enjoyment of social interactions. While bariatric surgery is the most effective treatment targeting severe obesity, there is limited understanding as to whether patients experience social interactions differently after surgery. The Bariatric Surgery and Social Experiences study is designed to assess potential changes in how much patients enjoy and engage in daily social interactions 1 year after Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG).
Single-centre, non-randomised clinical trial carried out at the Department of Endocrinology, Obesity and Nutrition at Vestfold Hospital Trust, Norway. Eligible patients (N=113) will undergo either RYGB, SG or single anastomosis sleeve ileal (SASI) bypass. The primary outcome measure is change in the social experience score (assessed with a questionnaire) from a presurgery to a follow-up assessment 1 year after RYGB and SG. The respective changes after SASI bypass will be assessed and considered exploratory.
The most recent protocol version of this study was reviewed and approved by the Regional Committee for Medical Research Ethics South East Norway (REK sør-øst A) on 29 August 2022 (ref: 238406). The results will be disseminated to academic and health professional audiences and the public via publications in international peer-reviewed journals and conferences.
NCT05207917.
肥胖与孤独感增加和社交互动享受减少有关。虽然减重手术是针对严重肥胖症最有效的治疗方法,但对于患者在手术后社交互动方式是否会发生变化,我们的了解有限。Bariatric Surgery and Social Experiences 研究旨在评估 Roux-en-Y 胃旁路术(RYGB)或袖状胃切除术(SG)后 1 年患者在享受和参与日常社交互动方面的潜在变化。
在挪威 Vestfold 医院信托内分泌科、肥胖和营养科进行的单中心、非随机临床试验。符合条件的患者(N=113)将接受 RYGB、SG 或单吻合口袖状空肠旁路术(SASI)。主要结局指标是 RYGB 和 SG 术前至术后 1 年随访评估时社会体验评分的变化(通过问卷调查评估)。将评估并考虑 SASI 旁路术后的相应变化。
该研究最近的方案版本于 2022 年 8 月 29 日由挪威东南部地区医学研究伦理委员会(REK sør-øst A)审查和批准(编号:238406)。研究结果将通过在国际同行评议期刊和会议上发表论文,向学术和卫生专业人士以及公众传播。
NCT05207917。